Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2023

Jul 15, 2023

33018_dirs_2023-07-14_a690be52-58d1-4d01-baff-e47d90425b6c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2023-07-12

Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-07-12 Common Stock A 10087 $0.00 Acquired 60571 Direct

Footnotes

F1: Represents the issuance of restricted stock units ("RSUs"). The RSUs vest and become exercisable in 3 equal annual installments beginning on July 12, 2024.